featured
Clinical Outcomes After Taxane Rechallenge in Patients With HER2-Negative Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Breast
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results
Breast 2023 Feb 04;68(2023)149-156, M Réda, A Fouquier, I Desmoulins, D Mayeur, C Kaderbhai, S Ilie, A Hennequin, B Coudert, A Bertaut, S LadoireFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.